117 related articles for article (PubMed ID: 7545506)
21. Plasma levels of insulin-like growth factor binding protein-4 (IGFBP-4) under normal and pathological conditions.
Van Doorn J; Cornelissen AJ; Van Buul-Offers SC
Clin Endocrinol (Oxf); 2001 May; 54(5):655-64. PubMed ID: 11380497
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia.
Blum WF; Ranke MB; Kietzmann K; Tönshoff B; Mehls O
Pediatr Nephrol; 1991 Jul; 5(4):539-44. PubMed ID: 1716946
[TBL] [Abstract][Full Text] [Related]
23. Effects of renal failure on the growth hormone-insulin-like growth factor axis.
Powell DR
J Pediatr; 1997 Jul; 131(1 Pt 2):S13-6. PubMed ID: 9255220
[TBL] [Abstract][Full Text] [Related]
24. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
25. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
26. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
27. Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay.
Van Doorn J; Ringeling AM; Shmueli SS; Kuijpers MC; Hokken-Koelega AC; van Buul-Offers SC; Jansen M
Clin Endocrinol (Oxf); 1999 May; 50(5):601-9. PubMed ID: 10468926
[TBL] [Abstract][Full Text] [Related]
28. Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents.
Hyun SE; Lee BC; Suh BK; Chung SC; Ko CW; Kim HS; Lee KH; Yang SW; Shin CH; Hwang JS; Kim DH; Lim BK; Kim JD; Yoo HW; Kim HS; Chung WY; Park MJ; Woo YJ; Kim CJ; Lee DY; Kim EY; Choi JH; Han HS; Hwang IT; Kim HS
Clin Biochem; 2012 Jan; 45(1-2):16-21. PubMed ID: 22032863
[TBL] [Abstract][Full Text] [Related]
29. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation.
Holt RI; Baker AJ; Jones JS; Miell JP
Pediatr Transplant; 1998 Feb; 2(1):76-84. PubMed ID: 10084765
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
[TBL] [Abstract][Full Text] [Related]
31. Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment.
Mandel S; Moreland E; Nichols V; Hanna C; Lafranchi S
J Clin Endocrinol Metab; 1995 Jan; 80(1):190-4. PubMed ID: 7530256
[TBL] [Abstract][Full Text] [Related]
32. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.
Gargosky SE; Hasegawa T; Tapanainen P; MacGillivray M; Hasegawa Y; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jun; 76(6):1631-7. PubMed ID: 7684745
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone treatment in growth retarded children with end stage renal failure: effect on free/dissociable IGF-I levels.
Bereket A; Lang CH; Blethen SL; Kaskel FJ; Stewart C; Wilson TA
J Pediatr Endocrinol Metab; 1997; 10(2):197-202. PubMed ID: 9364353
[TBL] [Abstract][Full Text] [Related]
34. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency.
Hasegawa Y; Hasegawa T; Aso T; Kotoh S; Nose O; Ohyama Y; Araki K; Tanaka T; Saisyo S; Yokoya S
Eur J Endocrinol; 1994 Jul; 131(1):27-32. PubMed ID: 7518726
[TBL] [Abstract][Full Text] [Related]
35. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
Bereket A; Lang CH; Blethen SL; Ng LC; Wilson TA
Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
[TBL] [Abstract][Full Text] [Related]
36. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
[TBL] [Abstract][Full Text] [Related]
37. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children.
Wan Nazaimoon WM; Osman A; Wu LL; Khalid BA
Clin Endocrinol (Oxf); 1996 Jul; 45(1):79-83. PubMed ID: 8796142
[TBL] [Abstract][Full Text] [Related]
38. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
39. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes.
Argente J; Barrios V; Pozo J; Muñoz MT; Hervás F; Stene M; Hernández M
J Clin Endocrinol Metab; 1993 Dec; 77(6):1522-8. PubMed ID: 7505288
[TBL] [Abstract][Full Text] [Related]
40. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
